Table 1.
Characteristics of control and acute rejection (AR) patients in follow-up TreaT-assay.
| Parameter | Control patients (No DGF, no AR) n = 10 |
AR-patients n = 2 |
|
|---|---|---|---|
| Recipient | Age year, median (range) | 64.5 (31–77) | 73.5 (73–74) |
| Sex male/female | 8/2 | 2/0 | |
| Underlying renal disease | Glomerulonnephritis (n = 3), diabetic nephropathy (n = 1), hypertensive nephropathy (n = 1), chronic pyelonephritis (n = 1), interstitial nephritis (n = 1), CNI-toxicity after previous lung-tx (n = 1) and unknown (n = 2) | Autosomal dominant polycistic kidney disease (n = 1), glomerulonephritis (n = 1) | |
| Previous kidney transplant | 10% | 50% | |
| Previous transplant other than kidney | 10% | 0% | |
|
Time on dialysis before Tx years, median (range) |
5 (3–11) | 12 (12) | |
| Current PRA | 0% | 0% | |
| Induction immunosuppression | Basiliximab | Basiliximab | |
| Maintenance immunosuppression |
Tacrolimus, mycophenolat-mofetil, methylprednisolone (n = 9) Cyclosporine, everolimus, methylprednisolone (n = 1) |
Tacrolimus, mycophenolate-mofetil, methylprednisolone | |
| Donor-recipient |
HLA-mismatches broad median (range) |
4 (0–6) | 5 (4–6) |
|
Cold ischemia time hours, median (range) |
7 (4–17) | 12 (9–15) | |
| Donor | Age year, median (range) | 59 (23–74) | 75 (74–76) |
| Sex male/female | 4/6 | 1/1 | |